跳至主要内容
临床试验/ISRCTN09524995
ISRCTN09524995已完成未知

A randomised, double-blind, cross-over, placebo controlled clinical trial to demonstrate the proof of concept for a product designed to protect against development of head louse infestation

Thornton & Ross Ltd (UK)0 个研究点目标入组 68 人开始时间: 2012年10月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Both males and females attending school with no upper age limit, although they must be the youngest qualifying member of the household
  • 2. People who are confirmed to be at risk of infestation with head lice
  • 3. People who give written informed consent, or if the participant is under 16 years of age whose parent/guardian gives written informed consent to participate in the study
  • 4. People who will be available for home visits by study team members over the 14 weeks of the study

排除标准

  • 1. People with a known sensitivity to any of the ingredients in Octanediol 1% Solution, Hedrin Once liquid gel or the placebo leave in conditioner preparation
  • 2. People with a secondary bacterial infection of the scalp (e.g. impetigo) or who have a long term scalp condition (e.g. psoriasis of the scalp)
  • 3. Pregnant or nursing mothers
  • 4. People who have participated in another clinical study within 1 month before entry to this study
  • 5. People who have already participated in this clinical study

研究者

发起方
Thornton & Ross Ltd (UK)

相似试验